biote Corp. (BTMD) Q1 2026 Earnings Call Transcript
biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago.
biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.1 per share a year ago.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 6 | $16 | $13.56 | -$2.44 | -15.25% |
Joseph Castro Nuveen LLC | 36,459 | $121,408.47 | $82,032.75 | -$39,375.72 | -32.43% |
Michael Braner 325 Capital LLC | 4.55M | $28.7M | $10.28M | -$18.42M | -64.19% |
Bobby Adusumilli SJS Investment Consulting Inc. | 3 | $4.05 | $6.39 | $2.34 | 57.78% |
Amna Ali Khan GDS Wealth Management | 42,789 | $319,633.83 | $96,917.08 | -$222,716.75 | -69.68% |
| Biotechnology Industry | Healthcare Sector | Bret Christensen CEO | NASDAQ (NMS) Exchange | 090683103 CUSIP |
| US Country | 223 Employees | - Last Dividend | - Last Split | 28 Apr 2021 IPO Date |
Biote Corp. is a company deeply embedded in the hormone optimization industry. It specializes in a niche yet crucial aspect of healthcare—hormone optimization, focusing primarily on the use of bioidentical hormone replacement pellet therapy to address hormonal imbalances in both men and women. Biote stands out in the market by offering a comprehensive platform known as the Biote Method. This platform not only involves educating, training, and certifying healthcare professionals such as physicians and nurse practitioners but also extends to providing robust practice management solutions. These solutions are designed to streamline the operations of practitioners who specialize in hormone optimization, empowering them to better manage their inventory, patient data, and overall administrative tasks with greater efficiency. Established in 2012, Biote Corp. has positioned its headquarters in Irving, Texas, marking its presence in the medical field by focusing on an area that directly impacts the wellbeing and quality of life of its patients.
This flagship offering encompasses a full range of services aimed at building and enhancing the practices of hormone optimization specialists. It includes education, training, and certification for practitioners, covering the latest in hormone optimization therapies and best practices. Beyond enhancing professional expertise, the Biote Method extends into comprehensive practice management software. This software solution is designed for the seamless ordering, tracking, and management of hormone optimization product inventories, as well as other administrative tasks, helping certified practitioners optimize their practice operations.
Integral to the Biote Method, this software is specifically tailored to the needs of hormone optimization professionals. It enables Biote-certified practitioners to efficiently manage their practice by streamlining the process of ordering, tracking, and managing both hormone optimization product inventory and patient-related administrative requirements. Its user-friendly interface and specialized features make it an indispensable tool for practitioners looking to simplify their workflow and focus more on patient care.
Another facet of Biote's technological offerings, this software is focused on managing pellet inventory—a key component in hormone replacement therapy. It ensures that practitioners can keep an accurate account of their hormone pellet stock levels, thereby avoiding shortages or overstock situations. This system is especially critical for maintaining the continuity of therapy sessions, ensuring that patients' treatments proceed without interruption.
Biote extends its brand into the realm of dietary supplements, offering products specifically designed to support the hormone optimization process. These supplements are marketed under the Biote brand, aligning with the company's commitment to providing a holistic approach to hormone health.
As part of its comprehensive approach to hormone optimization, Biote also provides sterile pellet insertion kits. These kits are essential for the safe and effective administration of hormone pellets, used in conjunction with hormone optimization therapies for both male and female patients. The kits underscore Biote’s commitment to ensuring that practitioners have access to high-quality, reliable supplies necessary for delivering treatment.